|Articles|January 8, 2019
Turnover Within CRO Companies Remains Persistently High
Advertisement
CRO companies are battling high turnover levels, but a new report from BDO USA, LLP, finds that compensation strategies generally have not made enough adjustments to their compensation strategy to address this on going issue. This report examines compensation and benefits trends in the CRO industry over the last 10 years, with a special focus on clinical research associates.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5